- Takeda Pharmaceutical press release (TAK): Q1 EPS: ¥154 vs ¥151 Y/Y (+1.5%; -11.8% CER).
- Revenue of ¥1.22T (-99.9% Y/Y)
- Operating profit: ¥358.9B vs ¥321.8B Y/Y (+11.5%; -0.5% CER).
- Q1 Operating margin: 29.4% vs 29.1% (+0.3 percentage points).
- Q1 Net profit: ¥242.9B
Takeda Pharmaceutical reports Q1 results (TAK:NYSE)
